NEUROCRINE BIOSCIENCES INC

NBIX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001724097-26-000007
Filing date: Mar 5, 2026
Earliest execution date: Mar 4, 2026
Reporting Owners: ABERNETHY MATT (CFO)
SEC Filing link

Summary

Type

Neutral

Net shares

-2,249

% of shares

-4.99%

Amount (USD)

$0

Insider confidence score

27.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Negative

  • Large discretionary sell (≥1% of shares)

Stock transactions

Transaction 1

Security

Common Stock

Action

Grant

Date

2026-03-04

Code

G

Net shares

-2,249.0

Acquired/Disposed

Disposed

Shares Owned Before

45,057.0

Shares Owned After

42,808.0

Filing's footnotes

1. This transaction represents a gift/charitable contribution effective March 4, 2026. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.

2. Includes an aggregate of 176 shares purchased on February 27, 2026 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.